Press Release: RenalGuard : Late-Breaking REMEDIAL III Clinical Trial Presented at TCT Shows RenalGuard Therapy's Automated, Personalized Hydration Superior in Preventing Contrast-Induced Acute Kidney Injury

MILFORD, Mass., Oct. 3, 2019 /PRNewswire/ -- RenalGuard Solutions , a pioneering medical device company focused on protecting patients from acute kidney injury (AKI), announced today that a late-breaking clinical trial found the company's RenalGuard Therapy® superior to the POSEIDON...